The company behind popular weight-loss drugs failed to disclose millions of pounds it paid to healthcare groups and patient ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it ...

In a tearful video posted to Instagram, the 30-year-old from Pheonix, Arizona admitted she took the drug after struggling ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.